The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in co...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8c5b8ee90d8c4f3eb4d30df870e01f9a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:8c5b8ee90d8c4f3eb4d30df870e01f9a2021-11-03T18:56:10ZThe Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-192150-751110.1128/mBio.03372-20https://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a2021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.03372-20https://doaj.org/toc/2150-7511 Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in concert with other components of the immune system.Arturo CasadevallLiise-anne PirofskiMichael J. JoynerAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 2 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Microbiology QR1-502 |
| spellingShingle |
Microbiology QR1-502 Arturo Casadevall Liise-anne Pirofski Michael J. Joyner The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| description |
Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in concert with other components of the immune system. |
| format |
article |
| author |
Arturo Casadevall Liise-anne Pirofski Michael J. Joyner |
| author_facet |
Arturo Casadevall Liise-anne Pirofski Michael J. Joyner |
| author_sort |
Arturo Casadevall |
| title |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| title_short |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| title_full |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| title_fullStr |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| title_full_unstemmed |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 |
| title_sort |
principles of antibody therapy for infectious diseases with relevance for covid-19 |
| publisher |
American Society for Microbiology |
| publishDate |
2021 |
| url |
https://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a |
| work_keys_str_mv |
AT arturocasadevall theprinciplesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 AT liiseannepirofski theprinciplesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 AT michaeljjoyner theprinciplesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 AT arturocasadevall principlesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 AT liiseannepirofski principlesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 AT michaeljjoyner principlesofantibodytherapyforinfectiousdiseaseswithrelevanceforcovid19 |
| _version_ |
1718445467694530560 |